Clinical Trial Update: A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for GB201 in combination with weekly paclitaxel and low-dose gemcitabine in metastatic pancreatic cancer is currently recruiting (Phase 2/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• GB201
• PACLITAXEL (PACLITAXEL)
• gemcitabine (low-dose) (gemcitabine)

Snippet

Sponsor: 1Globe Health Institute LLC | Conditions: Metastatic Pancreatic Cancer | Phase 2, Phase 3 | Status: RECRUITING